How to Identify Tests by Code Names

You are here:
Estimated reading time: 1 min

When searching cases in Natera Care, LIMS and, AMD you won’t be able to find the commercial names but their coded names.

PANORAMA 

Known as NIPT or noninvasive prenatal test, this blood sample can be performed as early as nine weeks gestation. It is applicable for twin pregnancies, and Panorama helps the mother monitor the baby’s health throughout pregnancy. Additionally, this test can determine the baby’s gender.

NIPT-TRI15 (single panel)
NIPTTRI22Q17 (single panel with 22Q)
NIPTTRIMD17 (microdeletions)
PANORAMA TWINS – TWINSZYGOSITY

VISTARA

It is the most comprehensive prenatal screening test for serious genetic conditions, which may affect the quality of life and require early intervention.

SNV_Sendout
VISTARA

HORIZON

This carrier disease screening test helps partners determine if there are any diseases that could be passed to their future baby. The test can be taken before getting pregnant or during pregnancy.

Horizon – Carrier_Screening
Horizon – Carrier_Screening2
Horizon – Carrier_Screening3
Horizon – Carrier_ScreeningSOPL
HCS
HZNV3H14
YSHCS274-CP
HORIZON-CF, HORIZON-SMA
YSHCS4FRAX-CP

ANORA

It helps determine the cause of a miscarriage or why the mother lost the baby, assisting them in preparing for future pregnancies.

Anora – Product_POC
Anora – Paraffin_POC
POC_15

EMPOWER

This is a genetic test designed for individuals who wish to assess their risk of developing cancer or explore treatment options following a cancer diagnosis. We analyze more than 12 types of cancer.

Empower – Hereditary_Cancer
HCT_3 or HCT_4

SPECTRUM

This test, known as PGT or PGTA, is used for in vitro fertilization or embryo biopsy. It helps improve the chances of a healthy pregnancy.

PRODUCT_1
PRODUCT_1_2
SPECTRUM_NGS
P1 FROZEN,COURIER DOMESTIC
P2 SPECTRUM PGD PGS

RENASIGHT

Is a test to determine if there is a genetic cause, anomaly or kidney disease. It is for adults and kids.

RENAL_GENETICS

PROSPERA

Is a transplant rejection test that uses a simple blood draw to evaluate the risk of rejection of a transplanted organ.

TX_V2

SIGNATERA

This test helps to identify if cancer is still present and helps the patient to have a discussion with the doctor regarding the treatment journey.

RM_BLOOD / RM_TISSUE

ALTERA

This test helps identify tumors and determine the most effective treatment for the patient’s cancer.

RM_TISSUE

 

 

 

 

Last update by: Claudia F (August 12, 2024)

Views: 9431